PRA provides a comprehensive range of pharmacovigilance solutions for the entire product life cycle. We deliver flexible and customized services with the ultimate goal of minimizing risk and protecting patient safety. We work in a cross-functional fashion with other solution areas, such as Real World Solutions and Therapeutic Expertise, to better assist clients with the effective management of their drug safety information and provide comprehensive pharmacovigilance services across all phases and key therapeutic areas.
Explore related content and topics
White Paper
Sponsor and CRO Pharmacovigilance Alliances
Outsourcing pharmacovigilance activities is a standard business practice in a continuously expanding market segment. In the past, outsourced safety…
Newsletter
Pharmacovigilance Nugget #2 Generating a DSUR - November 2017
A Development Safety Update Report (DSUR) is a periodic regulatory safety report used for drugs under development and for marketed products that are…
Fact Sheet
Risk-Based Approach to Clinical Development
PRA’s risk-based approach to clinical development represents a comprehensive approach to clinical study risk management and includes centralized…